More than a decade after earning FDA approval for Xiaflex as a nonsurgical treatment option for Dupuytren’s contracture, Endo is debuting its first-ever branded TV commercial in the indication. In a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results